Biofrontera
BFRIW
7 hedge funds and large institutions have $7K invested in Biofrontera in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
75% more funds holding
Funds holding: 4 → 7 (+3)
0.37% less ownership
Funds ownership: 1.2% → 0.83% (-0.37%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
80% less capital invested
Capital invested by funds: $35.2K → $7K (-$28.2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.07K |
| 2 |
CS
Clear Street
New York
|
+$31 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$9 |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$9.6K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
-$9 |
BFRIW Hedge Fund Activity: Q3 2023 in Review
7 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q3 2023, worth a combined $7K — down 80% from $35.2K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BFRIW positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.07K. The largest seller was Osaic Holdings, cutting an estimated $9.6K.
- 7 institutional investors held Biofrontera (BFRIW) as of Q3 2023, up from 4 in Q2 2023.
- Funds reported $7K of Biofrontera stock for Q3 2023, down 80% quarter-over-quarter.
- 3 funds opened new Biofrontera positions in Q3 2023 and 0 closed out, a net change of +3 holders.
- The largest Biofrontera buyer in Q3 2023 was Susquehanna International Group, an estimated $1.07K added.
- The largest Biofrontera seller in Q3 2023 was Osaic Holdings, an estimated $9.6K sold.
Based on aggregated 13F filings for Q3 2023.